New treatment option for the acute phase of the rare disease TTP
Thrombotic Thrombocytopenic Purpura (TTP) is a rare disorder caused by an enzyme deficiency. This can be heriditary or can be acquired as an autoimmune condition. Researchers have developed a treatment strategy to prevent this clotting in the blood vessels. Click through to read more.
See this content immediately after install